Publications
- Inhibitor of PCSK9 protein - alirocumab in clinical trials, ODYSSEY program2018 | First Faculty of Medicine
- Komentář ke studii (Trojkombinace atorvastatin perindopril/amlodipin v léčbě pacientů se stabilním onemocněním koronárních arterií - studie PAPA-CAD)2018 | First Faculty of Medicine
- Biologická léčba hypercholesterolemie2017 | First Faculty of Medicine
- The role of functional food and nutraceuticals in therapy of hypercholesterolemia of hypercholesterolemia of hypercholesterolemia2017 | First Faculty of Medicine
- Relationship of apolipoprotein E polymorfism on the functional fitness in the elderlyPublication without faculty affiliation
- Co s pacientem po infarktu myokardu (IM) v ambulanci praktického lékaře? Kdy potřebuje kardiologa?2023 | First Faculty of Medicine
- PCSK9 Inhibitors in Real-world Practice: Analysis of Data from 314 Patients and 2 Years of Experience in a Center of Preventive Cardiology2022 | First Faculty of Medicine
- Zahájení léčby arteriální hypertenze2022 | First Faculty of Medicine
- Lipid lowering therapy - proven treatment options and prospects for the near future2022 | First Faculty of Medicine
- Treatment of hypercholesterolemia in the Czech Republic - up to date2021 | First Faculty of Medicine
Loading network view...